Atlas Trials

Chemo/XRT +/- Amifostine to Assess Outcomes Related to Xerostomia, Mucositis, & Dysphagia

Clinical trial NCT00503776 · TERMINATED

Trial details

NCT number
NCT00503776
Sponsor
Vanderbilt-Ingram Cancer Center
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
DysphagiaHead and Neck CancerMucositisXerostomia
Start date
2006-01-01
Primary completion
2008-08-01
Enrollment
41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.